Ipilimumab and nivolumab in patients with metastatic clear cell renal cell carcinoma (mccRCC) treated on the phase 3 PDIGREE (A031704) trial: results from Step 1 analysis.
   Google Scholar   
Citation:
Meeting Instance:
ASCO 2025
Year:
2025
Type:
Abstract
Sub type:
Oral
Funding:
NCTN
Endpoint:
Primary
Analysis:
Preliminary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882; U10CA180888 (SWOG);  
Corr. Author:
 
Authors:
                                         
Networks:
CA043, CA249, GULFSOUTH, KAISER, LAPS-CO070, LAPS-MA036, LAPS-NC007, LAPS-NC010, LAPS-NY016, LAPS-OH007, LAPS-TN008, LAPS-TX011, LAPS-WI013, LAPS-WI020, NJ022   
Study
Alliance-A031704
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: